2/6/2008

Senicapoc, a novel small molecule therapy, helps maintain hydration of red blood cells and increase the level of hemoglobin in sickle cell anemia patients, according to new research. Senicapoc limits water and solute loss, preserving RBC hydration.

Full Story:
PhysOrg.com

Related Summaries